Pulse Biosciences, Inc. SEC filings PLSE
Pulse Biosciences, Inc. has 641 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 10-K, was filed on Feb 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Feb 27, 2026 | — |
| CORRESP | Letter to the SEC | Feb 25, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| NT 10-Q | Form nt 10-q | Aug 15, 2024 | Jun 30, 2024 |
| EFFECT | Filing | May 31, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| EFFECT | Filing | May 3, 2024 | — |
| CORRESP | Letter to the SEC | May 1, 2024 | — |
| CORRESP | Letter to the SEC | Apr 30, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 23, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2024 | — |
| CORRESP | Letter to the SEC | Apr 15, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2024 | — |
| EFFECT | Filing | Apr 8, 2024 | — |
| CORRESP | Letter to the SEC | Apr 4, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| EFFECT | Filing | Aug 30, 2023 | — |
| CORRESP | Letter to the SEC | Aug 29, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2022 | — |
| CORRESP | Letter to the SEC | Jul 14, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2022 | — |
| CORRESP | Letter to the SEC | Jun 9, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 25, 2022 | — |
| EFFECT | Filing | Sep 15, 2021 | — |
| CORRESP | Letter to the SEC | Sep 13, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2021 | — |
| D | Filing | Jul 9, 2021 | — |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| EFFECT | Filing | Aug 21, 2020 | — |
| CORRESP | Letter to the SEC | Aug 19, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2020 | — |
| EFFECT | Filing | May 8, 2020 | — |
| CORRESP | Letter to the SEC | May 7, 2020 | — |
| UPLOAD | Letter from the SEC | May 7, 2020 | — |
| CORRESP | Letter to the SEC | May 7, 2020 | — |
| CORRESP | Letter to the SEC | Apr 24, 2020 | — |
| CORRESP | Letter to the SEC | Apr 22, 2020 | — |
| CORRESP | Letter to the SEC | Apr 14, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2019 | — |
| CORRESP | Letter to the SEC | Sep 10, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 24, 2019 | — |
| EFFECT | Filing | Nov 6, 2018 | — |
| CORRESP | Letter to the SEC | Nov 2, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2018 | — |
| 8-K12B | Filing | Jun 18, 2018 | Jun 18, 2018 |
| EFFECT | Filing | May 21, 2018 | — |
| CORRESP | Letter to the SEC | May 17, 2018 | — |
| UPLOAD | Letter from the SEC | May 17, 2018 | — |
| D | Filing | Sep 28, 2017 | — |
| EFFECT | Filing | Jul 11, 2017 | — |
| EFFECT | Filing | Jul 11, 2017 | — |
| CORRESP | Letter to the SEC | Jul 7, 2017 | — |
| CORRESP | Letter to the SEC | Jul 7, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2017 | — |
| D | Filing | Feb 15, 2017 | — |
| CT ORDER | Filing | Jun 15, 2016 | — |
| CERTNAS | Auto-generated paper document | May 18, 2016 | — |
| EFFECT | Filing | May 13, 2016 | — |
| CORRESP | Letter to the SEC | May 10, 2016 | — |
| CORRESP | Letter to the SEC | May 10, 2016 | — |
| CORRESP | Letter to the SEC | May 10, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2016 | — |
| 8-A12B | Form 8-a12b | Apr 15, 2016 | — |
| CORRESP | Letter to the SEC | Mar 28, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2016 | — |
| CORRESP | Letter to the SEC | Mar 7, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2016 | — |
| D | Filing | Nov 13, 2014 | — |
Showing 78 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PLSE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1625101
- Former names
- Electroblate, Inc. (until Nov 13, 2014)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.